Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Borget

Showing results (11-20 of 133) with videos related to

Pageof 14
Sort By:
Current Medical Research and Opinion|January 11, 2023
Projecting overall survival in health-economic models: uncertainty and maturity of dataStéphane Roze, Nicolas Bertrand, Lauriane Eberst, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 31, 2014
Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic reviewChristos Chouaïd, Perinne Crequit, Isabelle Borget, et al.
Journal of Medical Internet Research|May 13, 2024
Suitability of the Current Health Technology Assessment of Innovative Artificial Intelligence-Based Medical Devices: Scoping Literature ReviewLine Farah, Isabelle Borget, Nicolas Martelli, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 23, 2016
New French Coverage with Evidence Development for Innovative Medical Devices: Improvements and Unresolved IssuesNicolas Martelli, Hélène van den Brink, Isabelle Borget
Annales D'Endocrinologie|October 25, 2022
SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Epidemiology and challenges in the management of thyroid nodulesFrancoise Borson-Chazot, Isabelle Borget, Muriel Mathonnet, et al.
Lung Cancer (Amsterdam, Netherlands)|December 9, 2008
Role of meta-analyses and of large randomized trials in the study of cancer treatmentsJean-Pierre Pignon, Anne Auperin, Isabelle Borget, et al.
The Lancet. Oncology|March 7, 2021
Imaging: towards a global solution to overcome the cancer pandemicIsabelle Borget, Nathalie Lassau, Corinne Balleyguier, et al.
Australian Health Review : a Publication of the Australian Hospital Association|September 7, 2015
Innovative medical devices and hospital decision making: a study comparing the views of hospital pharmacists and physiciansMathilde Billaux, Isabelle Borget, Patrice Prognon, et al.
International Journal of Clinical Pharmacy|May 11, 2018
Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapyFlorian Slimano, Florence Netzer, Isabelle Borget, et al.
Nature Reviews. Endocrinology|August 10, 2011
Treatment and follow-up of low-risk patients with thyroid cancerMartin Schlumberger, Isabelle Borget, Camila Nascimento, et al.
Pageof 14

Showing results (11-20 of 133) with videos related to

Sort By:
Pageof 14
Current Medical Research and Opinion|January 11, 2023
Projecting overall survival in health-economic models: uncertainty and maturity of dataStéphane Roze, Nicolas Bertrand, Lauriane Eberst, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 31, 2014
Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic reviewChristos Chouaïd, Perinne Crequit, Isabelle Borget, et al.
Journal of Medical Internet Research|May 13, 2024
Suitability of the Current Health Technology Assessment of Innovative Artificial Intelligence-Based Medical Devices: Scoping Literature ReviewLine Farah, Isabelle Borget, Nicolas Martelli, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 23, 2016
New French Coverage with Evidence Development for Innovative Medical Devices: Improvements and Unresolved IssuesNicolas Martelli, Hélène van den Brink, Isabelle Borget
Annales D'Endocrinologie|October 25, 2022
SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Epidemiology and challenges in the management of thyroid nodulesFrancoise Borson-Chazot, Isabelle Borget, Muriel Mathonnet, et al.
Lung Cancer (Amsterdam, Netherlands)|December 9, 2008
Role of meta-analyses and of large randomized trials in the study of cancer treatmentsJean-Pierre Pignon, Anne Auperin, Isabelle Borget, et al.
The Lancet. Oncology|March 7, 2021
Imaging: towards a global solution to overcome the cancer pandemicIsabelle Borget, Nathalie Lassau, Corinne Balleyguier, et al.
Australian Health Review : a Publication of the Australian Hospital Association|September 7, 2015
Innovative medical devices and hospital decision making: a study comparing the views of hospital pharmacists and physiciansMathilde Billaux, Isabelle Borget, Patrice Prognon, et al.
International Journal of Clinical Pharmacy|May 11, 2018
Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapyFlorian Slimano, Florence Netzer, Isabelle Borget, et al.
Nature Reviews. Endocrinology|August 10, 2011
Treatment and follow-up of low-risk patients with thyroid cancerMartin Schlumberger, Isabelle Borget, Camila Nascimento, et al.
Pageof 14